S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
NASDAQ:CONE

CyrusOne (CONE) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$90.36
$90.36
50-Day Range
$89.85
$90.45
52-Week Range
$66.17
$90.49
Volume
1 shs
Average Volume
2.84 million shs
Market Capitalization
$11.71 billion
P/E Ratio
430.29
Dividend Yield
2.30%
Price Target
N/A

CyrusOne MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
4.93%
From $4.26 to $4.47 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.95 out of 5 stars

Finance Sector

741st out of 817 stocks

Real Estate Investment Trusts Industry

163rd out of 176 stocks


CONE stock logo

About CyrusOne Stock (NASDAQ:CONE)

CyrusOne, Inc. is a real estate investment trust, which operates and develops enterprise-class, carrier-neutral, multi-tenant, and single-tenant data center properties. The firm provides data center facilities that protect and ensure the continued operation of IT infrastructure. Its data center properties are purpose-built facilities with redundant power, cooling and telecommunications systems that are not network-specific, enabling customer interconnectivity to a range of telecommunications carriers. The company was founded by David H. Ferdman in 2001 and is headquartered in Dallas, TX.


CONE Stock News Headlines

3-dimensional shapes - Edexcel
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Dr. Cone C. Rice
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Sami Cone Show: May 2023 p2
See More Headlines
Receive CONE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CyrusOne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2022
Today
2/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real Estate Investment Trusts
Sub-Industry
Office REITs
Current Symbol
NASDAQ:CONE
CUSIP
23283R10
Fax
N/A
Employees
441
Year Founded
N/A

Profitability

Net Income
$25.30 million
Pretax Margin
1.69%

Debt

Sales & Book Value

Annual Sales
$1.21 billion
Cash Flow
$3.95 per share
Book Value
$22.57 per share

Miscellaneous

Free Float
130,742,000
Market Cap
$11.71 billion
Optionable
Optionable
Beta
0.37

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives















CONE Stock Analysis - Frequently Asked Questions

How were CyrusOne's earnings last quarter?

CyrusOne Inc. (NASDAQ:CONE) announced its quarterly earnings data on Tuesday, February, 15th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $1.03 by $0.92. The real estate investment trust earned $318.40 million during the quarter, compared to analysts' expectations of $304.02 million. CyrusOne had a net margin of 2.10% and a trailing twelve-month return on equity of 1.02%. The company's revenue for the quarter was up 18.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.94 EPS.

Is CyrusOne a good dividend stock?

CyrusOne (NASDAQ:CONE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 2.30%. The dividend payout ratio is 990.48%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CONE will have a dividend payout ratio of 46.53% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CONE.

What other stocks do shareholders of CyrusOne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CyrusOne investors own include NVIDIA (NVDA), AT&T (T), Micron Technology (MU), AbbVie (ABBV), Enterprise Products Partners (EPD), Salesforce (CRM), Alibaba Group (BABA), Prologis (PLD), QUALCOMM (QCOM) and Walt Disney (DIS).

This page (NASDAQ:CONE) was last updated on 2/27/2024 by MarketBeat.com Staff